Truist lowered the firm’s price target on Intuitive Surgical (ISRG) to $590 from $605 and keeps a Buy rating on the shares following quarterly results. The firm says that while “not all roses,” overall the call and outlook were better vs. feared, considering the macro uncertainty. Truist stays long-term bull and sees Intuitive as a name long-term investors will add to/re-visit on macro pullbacks.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target lowered to $575 from $670 at Piper Sandler
- Intuitive Surgical price target lowered to $575 from $600 at Baird
- Intuitive Surgical: Strong Performance and Growth Potential Amidst Challenges
- Intuitive Surgical Reports Strong Q1 2025 Earnings
- Closing Bell Movers: Tesla jumps on Musk plans to pare back his DOGE work
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue